FDA
approval
· 2022-04-29
FDA Approved: ISIBLOOM — Supplemental Application (Xiromed, LLC.)
Summary
The FDA approved a supplemental application for ISIBLOOM, a desogestrel and ethinyl estradiol oral contraceptive from Xiromed, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ISIBLOOM (DESOGESTREL AND ETHINYL ESTRADIOL)